Demonstrated increased uptake of therapies in the liver by linking a GalNAc molecule to the antisense oligonucleotide

Demonstrated increased uptake of therapies in the liver by linking a GalNAc molecule to the antisense oligonucleotide

You are now leaving https://www.ionispharma.com to visit